IDBS wins Best Biologics Digitalization Award at Asia Pacific CMO Awards 2024

IDBS, a cloud software provider for BioPharma companies, received the Best Biologics Digitalization Award: Data Analytics for Quality Processes at the Asia Pacific Biologics CMO Excellence Awards on September 10, 2024. This award was determined by votes from over 10,000 professionals in the biologics, cell and gene therapy, and vaccine sectors across the Asia-Pacific region, highlighting the company's significant impact on digital transformation in life sciences. The Asia Pacific Biologics CMO Excellence Awards aim to recognize advancements in digitalization and artificial intelligence within the biologics industry. IDBS' innovative use of data analytics to improve quality processes in biologics manufacturing was a key factor in their recognition. The event took place at the Suntec Singapore Convention & Exhibition Centre, coinciding with the 3rd Biologics Contract Manufacturing Asia 2024 and the 8th Cell & Gene Therapy World Asia 2024. Pietro Forgione, General Manager of IDBS, expressed gratitude for the award, emphasizing the dedication and hard work of the team in advancing digitalization in the biologics sector. The event gathered over 300 industry leaders to celebrate achievements in the BioPharma sector, showcasing the importance of collaboration and innovation in driving progress. IDBS has over 30 years of experience in scientific informatics and process data management, serving a diverse range of customers, including 80% of the Top 20 BioPharma companies. Their solutions, such as IDBS E-WorkBook, IDBS Polar, and PIMS platforms, are designed to enhance decision-making in drug development and manufacturing, further solidifying their role as a leader in the industry.